Stay updated on BNT111 and Cemiplimab Combo for Melanoma Clinical Trial

Sign up to get notified when there's something new on the BNT111 and Cemiplimab Combo for Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BNT111 and Cemiplimab Combo for Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2026-01-14T04:01:30.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.3.3 and removes references to HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:51:03.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Version 31 (2025-11-27) shows that results have been posted and new sections for Adverse Events and Baseline Characteristics, along with an updated Study Status. The previous entry indicated Results Submitted, which has been replaced by posted results.
    Difference
    0.5%
    Check dated 2025-12-16T21:00:23.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added, replacing v3.2.0; this change is a site-wide UI version update and does not affect trial data or page purpose. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:53:05.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    - Removed the government funding status notice that previously appeared on the page, which warned about potential outages and delays.
    Difference
    0.5%
    Check dated 2025-11-18T07:15:25.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The latest version adds non-core UI elements and metadata to the record history, including sections such as More Information, Document Section, Eligibility, Outcome Measures, Baseline Characteristics, Participant Flow, and Adverse Events, along with a Quality Control status note (e.g., 'Quality Control Review Has Not Concluded') and a recent Returned date. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2025-11-11T03:00:41.000Z thumbnail image

Stay in the know with updates to BNT111 and Cemiplimab Combo for Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BNT111 and Cemiplimab Combo for Melanoma Clinical Trial page.